Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD)

CompletedOBSERVATIONAL
Enrollment

116

Participants

Timeline

Start Date

June 14, 2019

Primary Completion Date

June 30, 2025

Study Completion Date

June 30, 2025

Conditions
Limb Girdle Muscular DystrophyMuscular Dystrophies
Trial Locations (10)

21205

Kennedy Krieger Institute, Baltimore

23298

Virginia Commonwealth University, Richmond

43205

Nationwide Children's Hospital, Columbus

52242

University of Iowa, Iowa City

55455

University of Minnesota, Minneapolis

63110

Washington University School of Medicine, St Louis

66160

University of Kansas Medical Center, Kansas City

80045

The University of Colorado Anschutz Medical Campus, Aurora

92697

University of California Irvine, Irvine

Unknown

John Walton Muscular Dystrophy Research Centre (Newcastle Upon Tyne), Newcastle

All Listed Sponsors
collaborator

Newcastle University

OTHER

collaborator

Nationwide Children's Hospital

OTHER

collaborator

Washington University School of Medicine

OTHER

collaborator

University of Iowa

OTHER

collaborator

University of Minnesota

OTHER

collaborator

University of California, Irvine

OTHER

collaborator

Hugo W. Moser Research Institute at Kennedy Krieger, Inc.

OTHER

collaborator

University of Colorado, Denver

OTHER

collaborator

University of Kansas Medical Center

OTHER

lead

Virginia Commonwealth University

OTHER

NCT03981289 - Defining Clinical Endpoints in Limb Girdle Muscular Dystrophy (LGMD) | Biotech Hunter | Biotech Hunter